Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension

Circulation. 2015 Dec 1;132(22):2152-61. doi: 10.1161/CIRCULATIONAHA.114.012328.

¹ From Pulmonary and Critical Care Medicine, Center for Pulmonary Heart Disease (A.B.W.), Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (A.B.W.); and Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine, Boston, MA (H.W.F.). abwaxman@partners.org.
² From Pulmonary and Critical Care Medicine, Center for Pulmonary Heart Disease (A.B.W.), Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (A.B.W.); and Pulmonary Hypertension Center, Boston Medical Center, Boston University School of Medicine, Boston, MA (H.W.F.).

No abstract available

Keywords: clinical trial; hypertension, pulmonary; patient outcome assessment; performance measure.

Publication types